Next
- First published 2006
- 300 pages
- Spanish
Michael Crichton's Next delves into a world where the rapid advancements in genetic science blur ethical and legal lines. The novel explores the profound impact of bio-research on individuals and society, questioning the ownership of human cells, the unchecked use of new therapies, and the implications of cross-species genetic manipulation. Through multiple interconnected storylines, including a family battling for the rights to their own cancer-resistant genes and the existence of transgenic animals with human characteristics, Crichton presents a landscape where corporate greed and scientific ambition collide with personal autonomy. This narrative offers a blend of factual insight and speculative fiction, urging readers to consider the immediate and future consequences of our genetic capabilities.
What readers say
3.54
79K ratings across the web 5 in 10 readers loved it, 2 didn't like it
Michael Crichton's "Next" is frequently praised for its ambitious exploration of genetic engineering and its profound societal implications. Readers consistently highlight the book's ability to provoke thought, delving into complex topics like gene patenting, the corporatization of human genes, and the ethical dilemmas surrounding genetic manipulation. Many found it to be incredibly well-researched, praising Crichton's dedication to presenting factual bases for his fictional scenarios, which often left them learning a great deal and considering issues they previously knew nothing about. Despite its scientific depth, the book is often described as a page-turner, engaging, and fast-paced, offering a thrilling and timely look into a future that feels unsettlingly close to reality. Its thematic strength, particularly in exposing the potential for greed to warp scientific advancement, resonated strongly with many, who appreciated it as a poignant and even satirical warning.
However, "Next" also draws significant criticism, primarily regarding its narrative structure and execution. A common complaint is the book's lack of cohesion, with many reviewers finding it to be a collection of disparate stories or anecdotes rather than a unified plot. This episodic approach often led to an overwhelming number of characters, making them difficult to track and preventing meaningful development. While the extensive research was lauded, the sheer volume of medical and technical information, often presented didactically, was frequently cited as making the book a slow slog, boring, or confusing at times. Some readers felt the initial promise of the premise was squandered, leading to disappointment, a lack of action, or an unsatisfying ending where subplots either fizzled out or were tied together too neatly. Elements such as transgenic animals with human-like traits were also described as silly or over-exaggerated, detracting from the book's serious themes.
Overall, "Next" elicits a highly polarized response, praised for its intellectual depth and criticized for its narrative flaws. It shines as a thought-provoking "drama of ideas," effectively raising crucial questions about the ethics and legalities of genetic science. Readers who appreciate Michael Crichton's signature blend of science and fiction, particularly those interested in biotechnology, intellectual property law, and the ethical challenges of scientific advancement, are most likely to find this book compelling. It is recommended for those who enjoy a well-researched, discussion-generating read and are prepared for a less conventional story structure, prioritizing thematic exploration over a singular, tightly woven plot with deep character development.
However, "Next" also draws significant criticism, primarily regarding its narrative structure and execution. A common complaint is the book's lack of cohesion, with many reviewers finding it to be a collection of disparate stories or anecdotes rather than a unified plot. This episodic approach often led to an overwhelming number of characters, making them difficult to track and preventing meaningful development. While the extensive research was lauded, the sheer volume of medical and technical information, often presented didactically, was frequently cited as making the book a slow slog, boring, or confusing at times. Some readers felt the initial promise of the premise was squandered, leading to disappointment, a lack of action, or an unsatisfying ending where subplots either fizzled out or were tied together too neatly. Elements such as transgenic animals with human-like traits were also described as silly or over-exaggerated, detracting from the book's serious themes.
Overall, "Next" elicits a highly polarized response, praised for its intellectual depth and criticized for its narrative flaws. It shines as a thought-provoking "drama of ideas," effectively raising crucial questions about the ethics and legalities of genetic science. Readers who appreciate Michael Crichton's signature blend of science and fiction, particularly those interested in biotechnology, intellectual property law, and the ethical challenges of scientific advancement, are most likely to find this book compelling. It is recommended for those who enjoy a well-researched, discussion-generating read and are prepared for a less conventional story structure, prioritizing thematic exploration over a singular, tightly woven plot with deep character development.
Reviews
No reviews yet. Be the first.
Details & editions
- This edition
- Random House Mondadori, S.A, 2008
- ISBN
- 9780307391988
- Language
- Spanish
Original edition Next Originally published in 2006 · English · HarperCollins eBooks









